These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3602582

  • 1. Nonanticoagulant protective effect of heparin in chronic aminonucleoside nephrosis.
    Diamond JR, Karnovsky MJ.
    Ren Physiol; 1986; 9(6):366-74. PubMed ID: 3602582
    [Abstract] [Full Text] [Related]

  • 2. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J, Weening JJ, Elema JD.
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [Abstract] [Full Text] [Related]

  • 3. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR, Karnovsky MJ.
    J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200
    [Abstract] [Full Text] [Related]

  • 4. Differences in puromycin aminonucleoside nephrosis in two rat strains.
    Grond J, Muller EW, van Goor H, Weening JJ, Elema JD.
    Kidney Int; 1988 Feb; 33(2):524-9. PubMed ID: 3361753
    [Abstract] [Full Text] [Related]

  • 5. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study.
    Diamond JR, Pesek I.
    Lab Invest; 1991 Jan; 64(1):21-8. PubMed ID: 1990206
    [Abstract] [Full Text] [Related]

  • 6. Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation.
    Diamond JR, Karnovsky MJ.
    Kidney Int; 1987 Nov; 32(5):671-7. PubMed ID: 3430956
    [Abstract] [Full Text] [Related]

  • 7. Mesangial function and glomerular sclerosis in rats with aminonucleoside nephrosis.
    Grond J, Koudstaal J, Elema JD.
    Kidney Int; 1985 Feb; 27(2):405-10. PubMed ID: 3990093
    [Abstract] [Full Text] [Related]

  • 8. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
    Lee HS, Jeong JY, Kim BC, Kim YS, Zhang YZ, Chung HK.
    Kidney Int; 1997 Apr; 51(4):1151-9. PubMed ID: 9083281
    [Abstract] [Full Text] [Related]

  • 9. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y, Shirato I, Maeda A, Kobayashi N, Liao J, Shou I, Fukui M, Tomino Y.
    J Nephrol; 2002 Apr; 15(1):36-41. PubMed ID: 11936424
    [Abstract] [Full Text] [Related]

  • 10. Cell proliferation and apoptosis of the glomerular epithelial cells in rats with puromycin aminonucleoside nephrosis.
    Shiiki H, Sasaki Y, Nishino T, Kimura T, Kurioka H, Fujimoto S, Dohi K.
    Pathobiology; 1998 Apr; 66(5):221-9. PubMed ID: 9732237
    [Abstract] [Full Text] [Related]

  • 11. Study of anionic sites on the mesangium in aminonucleoside nephrosis.
    Ueda Y, Wada N, Hirabayashi K, Ono H, Iidaka K.
    Nihon Jinzo Gakkai Shi; 1989 Oct; 31(10):1001-9. PubMed ID: 2615011
    [Abstract] [Full Text] [Related]

  • 12. Treatment of hyperlipidemia with probucol suppresses the development of focal and segmental glomerulosclerosis in chronic aminonucleoside nephrosis.
    Hirano T, Morohoshi T.
    Nephron; 1992 Oct; 60(4):443-7. PubMed ID: 1584321
    [Abstract] [Full Text] [Related]

  • 13. Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis.
    Hagiwara M, Yamagata K, Capaldi RA, Koyama A.
    Kidney Int; 2006 Apr; 69(7):1146-52. PubMed ID: 16609681
    [Abstract] [Full Text] [Related]

  • 14. Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis.
    Huang S, Schaefer RM, Reisch S, Paczek L, Schaefer L, Teschner M, Sebekova K, Heidland A.
    Kidney Blood Press Res; 1999 Apr; 22(3):121-7. PubMed ID: 10394110
    [Abstract] [Full Text] [Related]

  • 15. The renal clearance of dextran sulfate decreases in puromycin aminonucleoside-induced glomerulosclerosis: a puzzle observation.
    Santos AM, Pomin VH, Stelling MP, Guimarães MA, Cardoso LR, Mourão PA.
    Clin Chim Acta; 2007 Aug; 383(1-2):116-25. PubMed ID: 17599817
    [Abstract] [Full Text] [Related]

  • 16. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats.
    Radin MJ, Wilke WL, Fettman MJ.
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):279-82. PubMed ID: 3538253
    [Abstract] [Full Text] [Related]

  • 17. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition.
    Diamond JR, Anderson S.
    Am J Pathol; 1990 Dec; 137(6):1323-32. PubMed ID: 2260622
    [Abstract] [Full Text] [Related]

  • 18. Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside.
    Diamond JR, Karnovsky MJ.
    Am J Pathol; 1986 Mar; 122(3):481-7. PubMed ID: 3953770
    [Abstract] [Full Text] [Related]

  • 19. A role for oxygen free radicals in aminonucleoside nephrosis.
    Diamond JR, Bonventre JV, Karnovsky MJ.
    Kidney Int; 1986 Feb; 29(2):478-83. PubMed ID: 3702206
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
    Schwartz MM, Sharon Z, Pauli BU, Lewis EJ.
    Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.